Loss of calreticulin function decreases NFκB activity by stabilizing IκB protein

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 11, 2014, Pages 2385-2393

  Massaeli, Hamid ^a   Jalali, Shahrzad ^b,c   Viswanathan, Divya ^a   Mesaeli, Nasrin ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b UNIVERSITY OF MANITOBA   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Calreticulin; I B; NF B; Okadaic acid; PP2A

Indexed keywords

CALRETICULIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEASOME; SERINE; THREONINE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; DNA BINDING; ENDOPLASMIC RETICULUM STRESS; GENE DELETION; GENE TARGETING; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84905234678     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.06.017     Document Type: Article

References (40)

1. Michalak M., Groenendyk J., Szabo E., Gold L.I., Opas M. Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem. J. 2009, 417:651-666.
2. Helenius A., Trombetta E.S., Herbert D.N., Simons J.F. Calnexin, calreticulin and the folding of glycoproteins. Trends Cell Biol. 1997, 7:193-200.
3. Hammond C., Helenius A. Quality control in the secretory pathway. Curr. Opin. Cell Biol. 1995, 7:523-529.
4. Knee R., Ahsan I., Mesaeli N., Kaufman R.J., Michalak M. Compromised calnexin function in calreticulin-deficient cells. Biochem. Biophys. Res. Commun. 2003, 304:661-666.
5. Uvarov A.V., Mesaeli N. Enhanced ubiquitin-proteasome activity in calreticulin deficient cells: a compensatory mechanism for cell survival. Biochim. Biophys. Acta 2008, 1783:1237-1247.
6. Mesaeli N., Phillipson C. Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells. Mol. Biol. Cell 2004, 15:1862-1870.
7. Jalali S., Aghasi M., Yeganeh B., Mesaeli N. Calreticulin regulates insulin receptor expression and its downstream PI3 kinase/Akt signalling pathway. Biochim. Biophys. Acta 2008, 1783:2344-2351.
8. Nakamura K., Bossy-Wetzel E., Burns K., Fadel M.P., Lozyk M., Goping I.S., Opas M., Bleackley R.C., Green D.R., Michalak M. Changes in endoplasmic reticulum luminal environment affect cell sensitivity to apoptosis. J. Cell Biol. 2000, 150:731-740.
9. Shishodia S., Aggarwal B.B. Nuclear factor-kappaB: a friend or a foe in cancer?. Biochem. Pharmacol. 2004, 68:1071-1080.
10. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18:2195-2224.
11. Schmitz M.L., Mattioli I., Buss H., Kracht M. NF-kappaB: a multifaceted transcription factor regulated at several levels. Chembiochem 2004, 5:1348-1358.
12. Quivy V., Van Lint C. Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation. Biochem. Pharmacol. 2004, 68:1221-1229.
13. Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 2006, 25:6685-6705.
14. Kanarek N., Ben-Neriah Y. Regulation of NF-kappaB by ubiquitination and degradation of the IkappaBs. Immunol. Rev. 2012, 246:77-94.
15. Kaneko M., Niinuma Y., Nomura Y. Activation signal of nuclear factor-kappa B in response to endoplasmic reticulum stress is transduced via IRE1 and tumor necrosis factor receptor-associated factor 2. Biol. Pharm. Bull. 2003, 26:931-935.
16. Chauncey S.S., Boothman D.A., Habib A.A. The receptor interacting protein 1 mediates a link between NFkappaB and PI3-kinase signaling. Cell Cycle 2009, 8:2671-2672.
17. Badr G., Saad H., Waly H., Hassan K., Abdel-Tawab H., Alhazza I.M., Ahmed E.A. Type I interferon (IFN-alpha/beta) rescues B-lymphocytes from apoptosis via PI3Kdelta/Akt, Rho-A, NFkappaB and Bcl-2/Bcl(XL). Cell. Immunol. 2010, 263:31-40.
18. Lentsch A.B., Ward P.A. The NFkappaBb/IkappaB system in acute inflammation. Arch. Immunol. Ther. Exp. 2000, 48:59-63.
19. Basu S., Srivastava P.K. Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity. J. Exp. Med. 1999, 189:797-802.
20. Obeid M., Tesniere A., Ghiringhelli F., Fimia G.M., Apetoh L., Perfettini J.L., Castedo M., Mignot G., Panaretakis T., Casares N., Metivier D., Larochette N., van Endert P., Ciccosanti F., Piacentini M., Zitvogel L., Kroemer G. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 2007, 13:54-61.
21. Kypreou K.P., Kavvadas P., Karamessinis P., Peroulis M., Alberti A., Sideras P., Psarras S., Capetanaki Y., Politis P.K., Charonis A.S. Altered expression of calreticulin during the development of fibrosis. Proteomics 2008, 8:2407-2419.
22. Perkins N.D. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 2006, 25:6717-6730.
23. Miskolci V., Castro-Alcaraz S., Nguyen P., Vancura A., Davidson D., Vancurova I. Okadaic acid induces sustained activation of NFkappaB and degradation of the nuclear IkappaBalpha in human neutrophils. Arch. Biochem. Biophys. 2003, 417:44-52.
24. Yang J., Fan G.H., Wadzinski B.E., Sakurai H., Richmond A. Protein phosphatase 2A interacts with and directly dephosphorylates RelA. J. Biol. Chem. 2001, 276:47828-47833.
25. Li S., Wang L., Berman M.A., Zhang Y., Dorf M.E. RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. Mol. Cell 2006, 24:497-509.
26. Huang X., Cheng A., Honkanen R.E. Genomic organization of the human PP4 gene encoding a serine/threonine protein phosphatase (PP4) suggests a common ancestry with PP2A. Genomics 1997, 44:336-343.
27. Wharry C.E., Haines K.M., Carroll R.G., May M.J. Constitutive non-canonical NFkappaB signaling in pancreatic cancer cells. Cancer Biol. Ther. 2009, 8:1567-1576.
28. K.S.S.S., Veeramohan H.P., Mathew T., S.S., C.M. Nifedipine inhibits hypoxia induced transvascular leakage through down regulation of NFkB. Respir. Physiol. Neurobiol. 2012, 183:26-34.
29. Li W., Li H., Bocking A.D., Challis J.R. Tumor necrosis factor stimulates matrix metalloproteinase 9 secretion from cultured human chorionic trophoblast cells through TNF receptor 1 signaling to IKBKB-NFKB and MAPK1/3 pathway. Biol. Reprod. 2010, 83:481-487.
30. Ghashghaeinia M., Toulany M., Saki M., Bobbala D., Fehrenbacher B., Rupec R., Rodemann H.P., Ghoreschi K., Rocken M., Schaller M., Lang F., Wieder T. The NFkB pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated erythrocytes. Cell. Physiol. Biochem. 2011, 27:45-54.
31. Antoon J.W., White M.D., Slaughter E.M., Driver J.L., Khalili H.S., Elliott S., Smith C.D., Burow M.E., Beckman B.S. Targeting NFkB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2. Cancer Biol. Ther. 2011, 11:678-689.
32. Thompson W.L., Van Eldik L.J. Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-3 through NFkB and MAPK dependent pathways in rat astrocytes [corrected]. Brain Res. 2009, 1287:47-57.
33. Wood K.M., Roff M., Hay R.T. Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB. Oncogene 1998, 16:2131-2139.
34. Miyamoto S., Chiao P.J., Verma I.M. Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines. Mol. Cell. Biol. 1994, 14:3276-3282.
35. Romashkova J.A., Makarov S.S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999, 401:86-90.
36. Madrid L.V., Mayo M.W., Reuther J.Y., Baldwin A.S. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 2001, 276:18934-18940.
37. Wu M., Massaeli H., Durston M., Mesaeli N. Differential expression and activity of matrix metalloproteinase-2 and -9 in the calreticulin deficient cells. Matrix Biol. 2007, 26:463-472.
38. Mesaeli N., Nakamura K., Zvaritch E., Dickie P., Dziak E., Krause K.H., Opas M., MacLennan D.H., Michalak M. Calreticulin is essential for cardiac development. J. Cell Biol. 1999, 144:857-868.
39. Lynch J., Guo L., Gelebart P., Chilibeck K., Xu J., Molkentin J.D., Agellon L.B., Michalak M. Calreticulin signals upstream of calcineurin and MEF2C in a critical Ca(2+)-dependent signaling cascade. J. Cell Biol. 2005, 170:37-47.
40. Holaska J.M., Black B.E., Love D.C., Hanover J.A., Leszyk J., Paschal B.M. Calreticulin is a receptor for nuclear export. J. Cell Biol. 2001, 152:127-140.